1. Food and Drug Administration website on breast implant associated ALCL. www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239996.htm. Accessed March 2017.
2. Clemens MW, Miranda RN. Coming of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg. 2015;42(4):605–13.
3. Ramos-Gallardo G, Cuenca-Pardo J, Rodríguez-Olivares E, Iribarren-Moreno R, Contreras-Bulnes L, Vallarta-Rodríguez A, Kalixto-Sanchez M, Hernández C, Ceja-Martinez R, Torres-Rivero C. Breast implant and anaplastic large cell lymphoma meta-analysis. J Investig Surg. 2016;18:1–10.
4. Gidengil CA, Predmore Z, Mattke S, van Busum K, Kim B. Breast implant associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015;135(3):713–20.
5. Clemens MW, Nava MB, Rocco N, Miranda RN. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017;6(2):169–84.